A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

Thumbnail Image

Files

A randomized, open.pdf (265.38 KB)

Date

2022-09-26

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Frontiers in Medicine

Abstract

Description

Keywords

Citation

URI

10.3389/fmed.2022.956123
 https://repository.run.edu.ng/handle/123456789/5810

Collections

Department of Biological Sciences

Endorsement

Review

Supplemented By

Referenced By